CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Although inhibitors targeting tumor angiogenic pathway have provided improvement for clinical treatment in patients with various solid tumors, the still very limited anti‐cancer efficacy and acquired drug resistance demand new agents that may offer better clinical benefits. In the effort to find a s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Zhou, You, Shan, Song, Li, Zhi‐Bin, Xin, Li‐Jun, Pan, De‐Si, Yang, Qian‐Jiao, Liu, Ying‐Ping, Yue, Xu‐Peng, Liu, Xiao‐Rong, Gao, Ji‐Zhou, Zhang, Jin‐Wen, Ning, Zhi‐Qiang, Lu, Xian‐Ping
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378272/
https://ncbi.nlm.nih.gov/pubmed/28004478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13141
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars